SOPHARMA (SPH): Sales revenues for the first four months of 2017 - raport 25
Raport ESPI
UNI - EN REPORT No25/2017
For the first four months of this year, revenues from sales increased by 12% compared to the same period of 2016, including 1% increase of domestic sales and 18% increase of export sales.
Please, make the above information public.
